Erin Anne Kaufman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Erin Anne Kaufman has a total of 167 co-authors. Here are the top co-authors by number of shared publications:
- Sheila E. Crowell
University of Oregon
11 shared publications Sheila E. Crowell
Department of Psychiatry and Huntsman Mental Health Institute, University of Utah, Salt Lake City, UT, United States
8 shared publicationsBrianna Meddaoui
5 shared publications- Amanda V. Bakian
Department of Psychiatry & Huntsman Mental Health Institute, University of Utah School of Medicine, Salt Lake City, USA
4 shared publications - Anna R. Docherty
Department of Psychiatry University of Utah School of Medicine Salt Lake City Utah USA
4 shared publications - Eric T. Monson
Department of Psychiatry & Huntsman Mental Health Institute, University of Utah School of Medicine, Salt Lake City, USA
4 shared publications
Latest Publications
- Open Access
Improved Sleep and Clinical Outcomes Following a Single-Session Intervention among Adolescents with Borderline Personality Disorder Features
Borderline personality disorder (BPD) is a serious mental illness that often emerges in adolescence. Although efficacious treatments have been developed, they are often lengthy, expensive, inaccessible, and require specialized training to deliver. Optimizing BPD prevention and early treatment is an important public health priority. Disrupted sleep is closely linked to key BPD features, and prior research has documented a range of sleep problems among BPD samples that appear to worsen symptom course and duration. This intervention trial ( NCT04507308 ) assessed the effects of a single-session sleep-focused treatment on adolescent sleep and BPD-related symptoms. Fifty-seven adolescents (ages 13-18) with 3+ clinically impairing BPD features and at least some self-reported sleep-related difficulties participated with a caregiver. Participants completed baseline surveys, interviews, and 10-day ecological momentary assessment (EMA) protocol to examine BPD symptoms and sleep in daily life. Youth also collected at-home ambulatory electroencephalogram (EEG) recordings before undergoing the treatment informed by the Transdiagnostic Sleep and Circadian Intervention. Post-treatment, youth practiced their new sleep routine for approximately one month before undergoing reassessment (EMA, EEG, surveys). Many indices of sleep quantity and quality improved across both objective (EEG) and subjective assessments (EMA and self- and caregiver-report). Youth reported an earlier clock time at sleep onset and earlier waketime, more sleep, and fewer awakenings in daily life. Every sleep-related questionnaire score improved at post-intervention and was maintained at one-month follow-up. Multiple (though not all) indices of BPD symptoms also improved significantly. Findings suggest sleep may be a promising intervention target for at-risk youth.
Open AccessImproved Sleep and Clinical Outcomes Following a Single-Session Intervention among Adolescents with Borderline Personality Disorder Features
Borderline personality disorder (BPD) is a serious mental illness that often emerges in adolescence. Although efficacious treatments have been developed, they are often lengthy, expensive, inaccessible, and require specialized training to deliver. Optimizing BPD prevention and early treatment is an important public health priority. Disrupted sleep is closely linked to key BPD features, and prior research has documented a range of sleep problems among BPD samples that appear to worsen symptom course and duration. This intervention trial ( NCT04507308 ) assessed the effects of a single-session sleep-focused treatment on adolescent sleep and BPD-related symptoms. Fifty-seven adolescents (ages 13-18) with 3+ clinically impairing BPD features and at least some self-reported sleep-related difficulties participated with a caregiver. Participants completed baseline surveys, interviews, and 10-day ecological momentary assessment (EMA) protocol to examine BPD symptoms and sleep in daily life. Youth also collected at-home ambulatory electroencephalogram (EEG) recordings before undergoing the treatment informed by the Transdiagnostic Sleep and Circadian Intervention. Post-treatment, youth practiced their new sleep routine for approximately one month before undergoing reassessment (EMA, EEG, surveys). Many indices of sleep quantity and quality improved across both objective (EEG) and subjective assessments (EMA and self- and caregiver-report). Youth reported an earlier clock time at sleep onset and earlier waketime, more sleep, and fewer awakenings in daily life. Every sleep-related questionnaire score improved at post-intervention and was maintained at one-month follow-up. Multiple (though not all) indices of BPD symptoms also improved significantly. Findings suggest sleep may be a promising intervention target for at-risk youth.
- Open Access
Clinical and Genetic Evaluation of Suicide Death with and without Interpersonal Trauma Exposure
Importance: Suicide is a leading cause of death in the United States with risk strongly influenced by Interpersonal trauma, contributing to treatment resistance and clinical complexity. Objective: To assess clinical and genetic factors in individuals who died from suicide, with and without interpersonal trauma exposure. Design: Individuals who died from suicide with and without trauma were compared in a retrospective case-case design. Prevalence of 19 broad clinical categories was assessed between groups. Results directed selection of 42 clinical subcategories, and 40 polygenic scores (PGS) for further assessment. Multivariable logistic regression models, adjusted for critical covariates and multiple tests, were formulated. Models were also stratified by age group (N = 1 091) and non-trauma exposed ( N = 7 647) individuals. A subset of unrelated European genotyped individuals was also assessed in PGS analyses (Trauma N = 491; Non-trauma N = 3 233). Exposures: “Trauma” is here defined as interpersonal trauma exposure, including abuse, assault, and neglect from International Classification of Disease coding. Main Outcomes and Measures: Prevalence of comorbid clinical sub/categories and PGS enrichment in trauma versus non-trauma exposed suicide deaths. Results: Overall, trauma-exposed individuals died from suicide earlier (mean age of 38.1 yo versus 43.3 yo; P <0.0001) and were disproportionately female (38% versus 21%, OR = 3.3, CI = 2.9-3.8). Prevalence of asphyxiation and overdose methods, prior suicidality, psychiatric diagnoses, and substance use (OR range = 1.3-3.7) were elevated in trauma exposed individuals who died from suicide. Genetic PGS were also elevated in trauma-exposed individuals who died from suicide for depression, bipolar disorder, cannabis use, PTSD, insomnia, and schizophrenia (OR range = 1.1-1.4) with ADHD and opioid use showing uniquely elevated PGS in trauma exposed males (OR range = 1.2-1.4). Conclusions and Relevance: Results demonstrated multiple convergent lines of age- and sex-specific evidence differentiating trauma-exposed from non-trauma exposed suicide death. Such findings suggest unique biological backgrounds and may refine identification and treatment of this high-risk group.
Open AccessClinical and Genetic Evaluation of Suicide Death with and without Interpersonal Trauma Exposure
Importance: Suicide is a leading cause of death in the United States with risk strongly influenced by Interpersonal trauma, contributing to treatment resistance and clinical complexity. Objective: To assess clinical and genetic factors in individuals who died from suicide, with and without interpersonal trauma exposure. Design: Individuals who died from suicide with and without trauma were compared in a retrospective case-case design. Prevalence of 19 broad clinical categories was assessed between groups. Results directed selection of 42 clinical subcategories, and 40 polygenic scores (PGS) for further assessment. Multivariable logistic regression models, adjusted for critical covariates and multiple tests, were formulated. Models were also stratified by age group (N = 1 091) and non-trauma exposed ( N = 7 647) individuals. A subset of unrelated European genotyped individuals was also assessed in PGS analyses (Trauma N = 491; Non-trauma N = 3 233). Exposures: “Trauma” is here defined as interpersonal trauma exposure, including abuse, assault, and neglect from International Classification of Disease coding. Main Outcomes and Measures: Prevalence of comorbid clinical sub/categories and PGS enrichment in trauma versus non-trauma exposed suicide deaths. Results: Overall, trauma-exposed individuals died from suicide earlier (mean age of 38.1 yo versus 43.3 yo; P <0.0001) and were disproportionately female (38% versus 21%, OR = 3.3, CI = 2.9-3.8). Prevalence of asphyxiation and overdose methods, prior suicidality, psychiatric diagnoses, and substance use (OR range = 1.3-3.7) were elevated in trauma exposed individuals who died from suicide. Genetic PGS were also elevated in trauma-exposed individuals who died from suicide for depression, bipolar disorder, cannabis use, PTSD, insomnia, and schizophrenia (OR range = 1.1-1.4) with ADHD and opioid use showing uniquely elevated PGS in trauma exposed males (OR range = 1.2-1.4). Conclusions and Relevance: Results demonstrated multiple convergent lines of age- and sex-specific evidence differentiating trauma-exposed from non-trauma exposed suicide death. Such findings suggest unique biological backgrounds and may refine identification and treatment of this high-risk group.
- Open Access
- 2 October 2025
- Published by Elsevier in Psychiatry Research
- Vol. 353, 116760
Defining and assessing international classification of disease suicidality phenotypes for genetic studies
- 2 October 2025
- Published by Elsevier in Psychiatry Research
- Vol. 353, 116760
Open AccessDefining and assessing international classification of disease suicidality phenotypes for genetic studies
- Open Access
- 6 August 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (8) , e0329849
Unveiling health disparities: Diagnostic prevalences in a transgender cohort versus matched controls
Importance: Transgender and gender-diverse (TGD) individuals are at risk for discrimination and inequities across legal, social, and medical contexts. Population-level resources have rarely been used for TGD health research and, therefore, data is lacking about prevalences of a wide range of clinical conditions among TGD populations. Objective: To leverage the Utah Population Database’s demographic, vital, and health records and examine population-level diagnostic prevalences in TGD individuals and an age-matched general cohort. Participants: 6,664 TGD individuals were identified using ICD codes for gender incongruence between 1995 and 2021; 64,124 age-matched individuals comprised the control cohort. Design: Using Phecodes to collapse ICD codes, this study examined differences in the prevalence of medical, mental health, and neurodevelopmental clinical phenotypes in TGD and control cohorts using modified Poisson regression models. Setting: Affiliated healthcare systems within the state of Utah. Main outcome and measure: We evaluated adjusted prevalence ratios of identified Phecodes. Results: The TGD cohort showed broadly higher documented prevalences of medical, mental health, and neurodevelopmental conditions compared to controls. Medical diagnoses more common in the TGD cohort included sleep disorders and chronic pain. Disparities in diagnoses such as “other endocrine disorders” and “need for hormone replacement therapy” likely reflect gender-affirming treatments. Mental health conditions including mood, depression, anxiety, and personality disorders were significantly more prevalent in the TGD cohort. Conclusions and Relevance: This study highlights diagnostic disparities for TGD individuals across multiple clinical categories. Our findings may be driven by: 1) discrimination and over-medicalization of TGD individuals, 2) differences in accessing and interacting with the healthcare system, and 3) variation in the true incidence of medical and mental health outcomes in the TGD vs control cohorts.
- 6 August 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (8) , e0329849
Open AccessUnveiling health disparities: Diagnostic prevalences in a transgender cohort versus matched controls
Importance: Transgender and gender-diverse (TGD) individuals are at risk for discrimination and inequities across legal, social, and medical contexts. Population-level resources have rarely been used for TGD health research and, therefore, data is lacking about prevalences of a wide range of clinical conditions among TGD populations. Objective: To leverage the Utah Population Database’s demographic, vital, and health records and examine population-level diagnostic prevalences in TGD individuals and an age-matched general cohort. Participants: 6,664 TGD individuals were identified using ICD codes for gender incongruence between 1995 and 2021; 64,124 age-matched individuals comprised the control cohort. Design: Using Phecodes to collapse ICD codes, this study examined differences in the prevalence of medical, mental health, and neurodevelopmental clinical phenotypes in TGD and control cohorts using modified Poisson regression models. Setting: Affiliated healthcare systems within the state of Utah. Main outcome and measure: We evaluated adjusted prevalence ratios of identified Phecodes. Results: The TGD cohort showed broadly higher documented prevalences of medical, mental health, and neurodevelopmental conditions compared to controls. Medical diagnoses more common in the TGD cohort included sleep disorders and chronic pain. Disparities in diagnoses such as “other endocrine disorders” and “need for hormone replacement therapy” likely reflect gender-affirming treatments. Mental health conditions including mood, depression, anxiety, and personality disorders were significantly more prevalent in the TGD cohort. Conclusions and Relevance: This study highlights diagnostic disparities for TGD individuals across multiple clinical categories. Our findings may be driven by: 1) discrimination and over-medicalization of TGD individuals, 2) differences in accessing and interacting with the healthcare system, and 3) variation in the true incidence of medical and mental health outcomes in the TGD vs control cohorts.
- Open Access
- 24 February 2025
- Published by Elsevier in Psychiatry Research
- Vol. 347, 116391
Absence of nonfatal suicidal behavior preceding suicide death reveals differences in clinical risks
- 24 February 2025
- Published by Elsevier in Psychiatry Research
- Vol. 347, 116391
Open AccessAbsence of nonfatal suicidal behavior preceding suicide death reveals differences in clinical risks
- Open Access
- 1 January 2025
- Published by Open Access Pub in Journal of Depression And Therapy
- Vol. 1 (4) , 28-40
Caregiver-Child Co-Rumination and Treatment Outcomes in a Randomized Clinical Trial of Rumination-Focused Cognitive-Behavioral Therapy
A number of developmental factors increase risk for adolescent rumination. This particular kind of repetitive negative thinking pattern often begins in the context of familial stressors and parental modeling. Though rumination can be effectively targeted with rumination-focused cognitive behavioral therapy (RF-CBT), it is unknown whether caregiver-child co-rumination (1) affects caregiver views of their child’s psychopathology, (2) or interferes with youth rumination- focused treatment. The present study uses data from a randomized clinical trial of RF-CBT to examine whether caregiver-child co-rumination, or caregivers’ own rumination patterns, are associated with bias in parental perception of their adolescent’s depression symptoms. We also examine if co-rumination scores at baseline moderate rumination scores for youth at treatment termination, and whether treatment effects dampen or decay more significantly post-treatment among youth with higher caregiver-child co-rumination. Youth (N = 76) were randomized to either 10-14 sessions of RF-CBT (n = 38) or treatment as usual (TAU; n = 38) and completed interviews and surveys at pre-treatment baseline, post-treatment, and 3-, 6-, 9-, and 12-month follow up. Results indicate that neither caregiver rumination nor co-rumination scores bias caregivers’ views of their child’s depression symptoms. In terms of reduction in child’s rumination scores, estimated treatment effects were larger for patients with higher baseline co - rumination scores, and there was no statistically significant difference in treatment effect decay over time in high versus low co-rumination groups. Results indicate co-rumination overall does not dampen the effect of RF-CBT, and those experiencing the highest levels of co-rumination may benefit most from treatment.
- 1 January 2025
- Published by Open Access Pub in Journal of Depression And Therapy
- Vol. 1 (4) , 28-40
Open AccessCaregiver-Child Co-Rumination and Treatment Outcomes in a Randomized Clinical Trial of Rumination-Focused Cognitive-Behavioral Therapy
A number of developmental factors increase risk for adolescent rumination. This particular kind of repetitive negative thinking pattern often begins in the context of familial stressors and parental modeling. Though rumination can be effectively targeted with rumination-focused cognitive behavioral therapy (RF-CBT), it is unknown whether caregiver-child co-rumination (1) affects caregiver views of their child’s psychopathology, (2) or interferes with youth rumination- focused treatment. The present study uses data from a randomized clinical trial of RF-CBT to examine whether caregiver-child co-rumination, or caregivers’ own rumination patterns, are associated with bias in parental perception of their adolescent’s depression symptoms. We also examine if co-rumination scores at baseline moderate rumination scores for youth at treatment termination, and whether treatment effects dampen or decay more significantly post-treatment among youth with higher caregiver-child co-rumination. Youth (N = 76) were randomized to either 10-14 sessions of RF-CBT (n = 38) or treatment as usual (TAU; n = 38) and completed interviews and surveys at pre-treatment baseline, post-treatment, and 3-, 6-, 9-, and 12-month follow up. Results indicate that neither caregiver rumination nor co-rumination scores bias caregivers’ views of their child’s depression symptoms. In terms of reduction in child’s rumination scores, estimated treatment effects were larger for patients with higher baseline co - rumination scores, and there was no statistically significant difference in treatment effect decay over time in high versus low co-rumination groups. Results indicate co-rumination overall does not dampen the effect of RF-CBT, and those experiencing the highest levels of co-rumination may benefit most from treatment.
- Open Access
- 18 November 2024
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 54 (15) , 4150-4159
Diagnostic profiles among suicide decedents with and without borderline personality disorder
Background: Borderline personality disorder (BPD) is a debilitating condition characterized by pervasive instability across multiple major domains of functioning. The majority of persons with BPD engage in self-injury and up to 10% die by suicide – rendering persons with this condition at exceptionally elevated risk of comorbidity and premature mortality. Better characterization of clinical risk factors among persons with BPD who die by suicide is urgently needed.Methods: We examined patterns of medical and psychiatric diagnoses (1580 to 1700 Phecodes) among persons with BPD who died by suicide (n = 379) via a large suicide death data resource and biobank. In phenotype-based phenome-wide association tests, we compared these individuals to three other groups: (1) persons who died by suicide without a history of BPD (n = 9468), (2) persons still living with a history of BPD diagnosis (n = 280), and (3) persons who died by suicide with a different personality disorder (other PD n = 589).Results: Multivariable logistic regression models revealed that persons with BPD who died by suicide were more likely to present with co-occurring psychiatric diagnoses, and have a documented history of self-harm in the medical system prior to death, relative to suicides without BPD. Posttraumatic stress disorder was more elevated among those with BPD who died by suicide relative to the other PD group.Conclusions: We found significant differences among persons with BPD who died by suicide and all other comparison groups. Such differences may be clinically informative for identifying high-risk subtypes and providing targeted intervention approaches.
- 18 November 2024
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 54 (15) , 4150-4159
Open AccessDiagnostic profiles among suicide decedents with and without borderline personality disorder
Background: Borderline personality disorder (BPD) is a debilitating condition characterized by pervasive instability across multiple major domains of functioning. The majority of persons with BPD engage in self-injury and up to 10% die by suicide – rendering persons with this condition at exceptionally elevated risk of comorbidity and premature mortality. Better characterization of clinical risk factors among persons with BPD who die by suicide is urgently needed.Methods: We examined patterns of medical and psychiatric diagnoses (1580 to 1700 Phecodes) among persons with BPD who died by suicide (n = 379) via a large suicide death data resource and biobank. In phenotype-based phenome-wide association tests, we compared these individuals to three other groups: (1) persons who died by suicide without a history of BPD (n = 9468), (2) persons still living with a history of BPD diagnosis (n = 280), and (3) persons who died by suicide with a different personality disorder (other PD n = 589).Results: Multivariable logistic regression models revealed that persons with BPD who died by suicide were more likely to present with co-occurring psychiatric diagnoses, and have a documented history of self-harm in the medical system prior to death, relative to suicides without BPD. Posttraumatic stress disorder was more elevated among those with BPD who died by suicide relative to the other PD group.Conclusions: We found significant differences among persons with BPD who died by suicide and all other comparison groups. Such differences may be clinically informative for identifying high-risk subtypes and providing targeted intervention approaches.
- Open Access
- 27 August 2024
- Published by Elsevier in JAACAP Open
- Vol. 3 (3) , 421-430
Characteristics of Youth Crisis App Users: Mental Health Service Access and Barriers and Perceptions of Helpfulness
- 27 August 2024
- Published by Elsevier in JAACAP Open
- Vol. 3 (3) , 421-430
Open AccessCharacteristics of Youth Crisis App Users: Mental Health Service Access and Barriers and Perceptions of Helpfulness
- 15 May 2024
- Published by Taylor & Francis in Identity
- Vol. 24 (3) , 243-256
Borderline Personality Features and Self-Injurious Urges: The Roles of Self-Concept Clarity and Bedtime Self-Critical Rumination
- 15 May 2024
- Published by Taylor & Francis in Identity
- Vol. 24 (3) , 243-256
Borderline Personality Features and Self-Injurious Urges: The Roles of Self-Concept Clarity and Bedtime Self-Critical Rumination